An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.
about
Novel strategies to enhance vaccine immunity against coccidioidomycosis.Preliminary evidence that the novel host-derived immunostimulant EP67 can act as a mucosal adjuvant.Card9- and MyD88-Mediated Gamma Interferon and Nitric Oxide Production Is Essential for Resistance to Subcutaneous Coccidioides posadasii InfectionProgress Toward a Human Vaccine Against CoccidioidomycosisEndemic mycoses in immunocompromised hosts.A novel C5a-derived immunobiotic peptide reduces Streptococcus agalactiae colonization through targeted bacterial killing.Vaccinated C57BL/6 mice develop protective and memory T cell responses to Coccidioides posadasii infection in the absence of interleukin-10.Interleukin-1 receptor but not Toll-like receptor 2 is essential for MyD88-dependent Th17 immunity to Coccidioides infection.Immune Response to Coccidioidomycosis and the Development of a Vaccine.Immunotherapy of Fungal Infections.The third annual BRDS on research and development of nucleic acid-based nanomedicines.Linear Epitopes of Paracoccidioides brasiliensis and Other Fungal Agents of Human Systemic Mycoses As Vaccine CandidatesAntifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi.Comparative analysis of immune effects in mice model: Clonorchis sinensis cysteine protease generated from recombinant Escherichia coli and Bacillus subtilis spores.Flow Cytometric Analysis of Protective T-Cell Response Against Pulmonary Coccidioides Infection.Intranasal Antifungal Vaccination Using DNA-Transfected Dendritic Cells.Rational Design of T Lymphocyte Epitope-Based Vaccines Against Coccidioides Infection.Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis.Complement in cancer: untangling an intricate relationship.Profiling dendritic cell subsets in head and neck squamous cell tonsillar cancer and benign tonsils.
P2860
Q35075092-0F7D3C5A-F4B4-4FAA-A535-66340471BBAAQ36315607-A2255895-E890-4F89-BACC-ED0C4D8C9305Q36728023-CFF698C5-BC7D-4B05-8F7B-B59ECDEB6163Q36749818-D62EF863-143A-4D2D-966F-1AD23861F98CQ37080529-D7060D5E-8E75-49F5-A446-26BFB7FE430CQ37263526-FCD242C6-28D8-4C93-A862-B96E9AB48A51Q37546521-7C70A118-F4CE-496A-A2AE-64F2100E2DE4Q37713371-DA1AFE53-520F-4AE2-8912-7707F3631FCDQ37731260-75736933-F1B0-474F-A011-3FDD372F3CCEQ38635409-D8F4505D-72C2-4F0A-9348-4C2EB5D6EB12Q39184710-4052294E-75A3-43B4-8F20-EC508974CE02Q39201536-52E5D114-57C4-42BF-92DA-DE64A741E1B8Q39338332-D324392E-97F2-431E-A727-A40EE6ABB65EQ39605791-D3709F84-E303-47A8-A7FE-DD630144B51CQ40109971-C2AE0399-2199-481D-A175-50C3E2159CA7Q40183804-D1661D6C-3B7E-4C5E-BEAD-69DDCD0AEB76Q40183816-C4142CBE-CBFB-4103-B6E2-4351519F755FQ40542327-5D3B24C6-6F32-4E49-8085-39B59CCF3597Q41584713-A5CF60EF-D533-47DF-AF46-A1998606C138Q50049007-A57A475A-53A2-49B6-A1B3-35DDF84A6871Q55081546-D4EA6AE0-75A7-4323-81FD-B37B7182522E
P2860
An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
An agonist of human complement ...... gainst Coccidioides infection.
@ast
An agonist of human complement ...... gainst Coccidioides infection.
@en
type
label
An agonist of human complement ...... gainst Coccidioides infection.
@ast
An agonist of human complement ...... gainst Coccidioides infection.
@en
prefLabel
An agonist of human complement ...... gainst Coccidioides infection.
@ast
An agonist of human complement ...... gainst Coccidioides infection.
@en
P2093
P2860
P1433
P1476
An agonist of human complement ...... against Coccidioides infection
@en
P2093
Brady J Hurtgen
Chiung-Yu Hung
Edward L Morgan
Garry T Cole
Sam D Sanderson
P2860
P304
P356
10.1016/J.VACCINE.2012.04.084
P407
P577
2012-05-08T00:00:00Z